Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Methicillin-resistant Staphylococcus Aureus (MRSA) Bacteremia”

24 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 24 results

Post-approval studies (Phase 4)Study completedNCT02660346
What this trial is testing

IL-10 Stratifying Tool for Towards Antibiotic Selection for MRSaB

Who this might be right for
Bacteremia
Sharp HealthCare 40
Not applicableLooking for participantsNCT05975671
What this trial is testing

Reducing Empiric VAncomycin Use in Pediatric Suspected Sepsis

Who this might be right for
SepsisSepsis MrsaSepsis Bacteremia+4 more
Children's Hospital of Philadelphia 52,500
Not applicableNo Longer AvailableNCT04597242
What this trial is testing

Expanded Access Study of Exebacase in COVID-19 Patients With Persistent MRSA Bacteremia

Who this might be right for
MRSA Bloodstream InfectionMRSA BacteremiaMRSA Right-sided Endocarditis+1 more
ContraFect
Post-approval studies (Phase 4)Looking for participantsNCT05137119
What this trial is testing

Staphylococcus Aureus Network Adaptive Platform Trial

Who this might be right for
Staphylococcus Aureus Bacteremia
University of Melbourne 8,000
Not applicableLooking for participantsNCT06958835
What this trial is testing

Linezolid Plus Standard of Care

Who this might be right for
Staphylococcus Aureus Bloodstream Infections (BSI; Bacteremia)
University Hospital, Basel, Switzerland 606
Testing effectiveness (Phase 2)Ended earlyNCT01975662
What this trial is testing

Vancomycin Versus Daptomycin for the Treatment of Methicillin Resistant Staphylococcus Aureus (MRSA) Bacteremia

Who this might be right for
Bacteremia Due to Staphylococcus Aureus
Singapore General Hospital 14
Not applicableStudy completedNCT01184339
What this trial is testing

Prospective Study Into the Performance of the MicroPhage S. Aureus/MSSA/MRSA Test Direct From Blood Culture Positives

Who this might be right for
Bacteremia
MicroPhage, Inc. 1,165
Post-approval studies (Phase 4)Looking for participantsNCT06637332
What this trial is testing

Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus Bacteremia

Who this might be right for
Staphylococcus Aureus SepticemiaStaphylococcus Aureus BacteremiaS. Aureus Bacteremia+2 more
Todd C. Lee MD MPH FIDSA 300
Post-approval studies (Phase 4)Ended earlyNCT00638157
What this trial is testing

Phase 4 Efficacy and Safety Study of Cubicin® With and Without Combination Therapy in S. Aureus Infective Endocarditis (SAIE)

Who this might be right for
Infective Endocarditis
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 24
Not applicableEnded earlyNCT01640886
What this trial is testing

Study of the Performance of the KeyPath MRSA/MSSA Blood Culture Test - BTA

Who this might be right for
Bacteremia
MicroPhage, Inc. 764
Not applicableStudy completedNCT00448942
What this trial is testing

The Impact of Chlorhexidine-Based Bathing on Nosocomial Infections

Who this might be right for
Nosocomial BacteremiaNosocomial FungemiaMRSA Colonization+3 more
Hunter Holmes Mcguire Veteran Affairs Medical Center 5,300
Large-scale testing (Phase 3)Study completedNCT01898338
What this trial is testing

Efficacy of Daptomycin Plus Fosfomycin Versus Daptomycin for Treatment of MRSA Bacteremia

Who this might be right for
Staph Aureus Methicillin Resistant Bacteremia
Miquel Pujol 167
Not applicableUnknownNCT00502476
What this trial is testing

Multicenter Trial of Daily Chlorhexidine Bathing to Reduce Nosocomial Infections

Who this might be right for
Nosocomial BacteremiaMRSA ColonizationMRSA Infection+2 more
Hunter Holmes Mcguire Veteran Affairs Medical Center 14,000
Testing effectiveness (Phase 2)Study completedNCT03643952
What this trial is testing

Safety, Efficacy, and Pharmacokinetics (PK) of Daptomycin (MK-3009) in Japanese Pediatric Subjects With Complicated Skin and Soft Tissue Infections (cSSTI) and Bacteremia (MK-3009-029)

Who this might be right for
BacteremiaSoft Tissue InfectionsSkin Diseases, Infectious
Merck Sharp & Dohme LLC 18
Large-scale testing (Phase 3)Ended earlyNCT01515020
What this trial is testing

Daptomycin Versus Vancomycin in the Treatment of Nosocomial or Healthcare-associated MRSA Bacteremia

Who this might be right for
Nosocomial InfectionHealthcare-associated Infection
Assistance Publique - Hôpitaux de Paris 10
Not applicableUnknownNCT01724671
What this trial is testing

Vancomycin Versus Ceftaroline in Patients With Infections Caused by MRSA That Are Susceptible to Ceftaroline

Who this might be right for
MRSA InfectionBacteremiaABSSSI+1 more
CPL Associates 30
Post-approval studies (Phase 4)Study completedNCT01701219
What this trial is testing

Safety and Efficacy Study of Ceftaroline in Subjects With Staphylococcus Aureus Bacteremia or With Persistent Methicillin-Resistant Staphylococcus Aureus Bacteremia

Who this might be right for
Staphylococcus Aureus BacteremiaMethicillin-resistant Staphylococcus Aureus (MRSA) Bacteremia
Forest Laboratories 56
Post-approval studies (Phase 4)Ended earlyNCT01287832
What this trial is testing

Vancomycin Versus Daptomycin for the Treatment of Methicillin-resistant Staphylococcus Aureus Bacteremia Due to Isolates With High Vancomycin Minimum Inhibitory Concentrations (MICs)

Who this might be right for
Bacteremia
St. John Health System, Michigan 11
Testing effectiveness (Phase 2)Ended earlyNCT03089697
What this trial is testing

Phase IIa Clinical Study of N-Rephasin® SAL200

Who this might be right for
Staphylococcus Aureus BacteremiaAnti-Bacterial Agents
Intron Biotechnology, Inc. 25
Not applicableUnknownNCT01352936
What this trial is testing

Comparison of Nephrotoxicity and Hospital Costs in Patients With Methicillin-Resistant Staphylococcus Aureus Bacteremia Who Received Vancomycin Versus Teicoplanin Therapy

Who this might be right for
Staphylococcus AureusBacteremia
Taipei Medical University WanFang Hospital 190
Load More Results